Stefanska Joanna, Stepien Karolina, Bielenica Anna, Szulczyk Daniel, Miroslaw Barbara, Koziol Anna E, Sanna Giuseppina, Iuliano Filippo, Madeddu Silvia, Jozwiak Michal, Struga Marta
Department of Pharmacogenomics, Faculty of Pharmacy, Medical University, 02-097 Warszawa, Poland.
Med Chem. 2016;12(5):478-88. doi: 10.2174/1573406412666151204003146.
A set of 21 thiourea derivatives were prepared through reacting 3-amino-1H-1,2,4-triazole with the commercial aliphatic and aromatic isothiocyanates. The aliphatic isothiocyanate was used as reagent leading to substitution on NH atom of 3-aminotriazole ring, whereas the triazole amino group was substituted when isothiocyanate group was bonded to the Csp2 hybridized atom, e.g. an aryl or C=O fragment. All compounds were evaluated in vitro for the antimicrobial activity. The derivatives 1, 2, 4, 8, 9, 10 and 12 showed the highest inhibition against Gram-positive cocci (S. aureus and S. epidermidis). The observed MIC values were in the range of 4-32 μg/mL. Compounds were also tested for their in vitro antimicrobial activity against the hospital methicillin-resistant strains of S. aureus. The observed MIC values varied from 4 to 64 μg/mL. The products 4 and 10 effectively inhibited the formation of biofilms of the methicillin-resistant and standard strains of S. epidermidis. The compound 10 was found to be more promising with IC50 values of 2-6 μg/mL as compared to the control. Moreover, the cytotoxicity against the MT-4 cells of all studied thioureas was evaluated. The compound 18 was significantly cytotoxic (CC50 = 8 μM).
通过使3-氨基-1H-1,2,4-三唑与市售脂肪族和芳香族异硫氰酸酯反应,制备了一组21种硫脲衍生物。脂肪族异硫氰酸酯用作试剂,导致3-氨基三唑环的NH原子发生取代,而异硫氰酸酯基团与sp2杂化的碳原子(如芳基或C=O片段)键合时,三唑氨基会被取代。对所有化合物进行了体外抗菌活性评估。衍生物1、2、4、8、9、10和12对革兰氏阳性球菌(金黄色葡萄球菌和表皮葡萄球菌)表现出最高抑制作用。观察到的最低抑菌浓度(MIC)值在4-32μg/mL范围内。还测试了这些化合物对医院耐甲氧西林金黄色葡萄球菌菌株的体外抗菌活性。观察到的MIC值在4至64μg/mL之间变化。产物4和10有效抑制了耐甲氧西林表皮葡萄球菌和标准菌株生物膜的形成。与对照相比,化合物10更具前景,其半数抑制浓度(IC50)值为2-6μg/mL。此外,评估了所有研究硫脲对MT-4细胞的细胞毒性。化合物18具有显著的细胞毒性(半数细胞毒性浓度CC50 = 8μM)。